acamprosate vs pramipexole
Side-by-side comparison of acamprosate and pramipexole Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Campral
Mirapex
Acamprosate is a medicine that can help you stay away from alcohol if you are alcohol-dependent and have already stopped drinking. It should be used with counseling and support.
Pramipexole extended-release tablets help treat Parkinson's disease. It belongs to a class of drugs called dopamine agonists.
Acamprosate helps people who are alcohol-dependent to not drink alcohol. You must have already stopped drinking before you start taking acamprosate. This medicine works best when it is part of a complete treatment plan that includes counseling and support.
This medicine treats Parkinson's disease. Parkinson's affects movement, causing stiffness, tremors, and slow motion. Pramipexole can help control these symptoms, so you can move more easily.
Acamprosate is similar to a natural substance in your brain. It is thought to work by helping to restore the normal balance of brain activity that is changed by long-term alcohol use. This can reduce your craving for alcohol.
Pramipexole works by acting like dopamine in the brain. Dopamine is a chemical that helps control movement. By mimicking dopamine, this medicine helps reduce Parkinson's symptoms.
- • Accidental injury
- • Weakness
- • Pain
- • Loss of appetite
- • Diarrhea
- • Feeling sleepy
- • Feeling sick to your stomach
- • Constipation
- • Dizziness
- • Feeling tired
- Low blood pressure 14
- Weakness 13
- Condition worsened 13
- Using the medicine for something it is not approved for 13
- Sudden kidney damage 12
- The medicine is not working 1,349
- Falling down 1,066
- Feeling tired 1,043
- Feeling sick to your stomach 832
- Aches and pains 795
Acamprosate may increase the risk of suicidal thoughts or actions. Your doctor should watch you for depression or suicidal thoughts. Tell your doctor right away if you have any new or worsening symptoms of depression or suicidal thoughts.
Pramipexole can make you fall asleep suddenly, even during normal daily activities. Tell your doctor if this happens. Pramipexole can also cause compulsive behaviors like gambling or overeating. Watch for these changes and tell your doctor if they occur.
Acamprosate may harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acamprosate passes into breast milk. Talk to your doctor if you are breastfeeding.
This medicine may harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if this medicine passes into breast milk. Pramipexole may also reduce breast milk production.
Also Compare — Nearby Drugs
Compare pramipexole with
How to Read This acamprosate vs pramipexole Comparison
acamprosate is classified in the GABA Analog (Alcohol Dependence) drug class, while pramipexole sits within the Dopamine Agonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acamprosate has 65 submissions while pramipexole has 5,085. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acamprosate and pramipexole — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.